Matches in Wikidata for { <http://www.wikidata.org/entity/Q59357430> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q59357430 description "article scientifique publié en 2018" @default.
- Q59357430 description "article" @default.
- Q59357430 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59357430 description "wetenschappelijk artikel" @default.
- Q59357430 description "наукова стаття, опублікована в серпні 2018" @default.
- Q59357430 name "The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection" @default.
- Q59357430 name "The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection" @default.
- Q59357430 type Item @default.
- Q59357430 label "The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection" @default.
- Q59357430 label "The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection" @default.
- Q59357430 prefLabel "The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection" @default.
- Q59357430 prefLabel "The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection" @default.
- Q59357430 P1433 Q59357430-798ABE9F-1A84-4F8C-AEE5-FB7AF1BEB20C @default.
- Q59357430 P1476 Q59357430-369E3C09-0833-405F-8BDB-11687810BBA4 @default.
- Q59357430 P2093 Q59357430-4E9E1793-77BD-46DB-A280-10F65D16BE0D @default.
- Q59357430 P2093 Q59357430-764D3637-C21C-4676-9560-85E1952AB16B @default.
- Q59357430 P304 Q59357430-77E0C17B-B412-4634-9C5B-3802437587E6 @default.
- Q59357430 P31 Q59357430-44D8A4D0-9B88-4C4E-9CA2-6B49E2971294 @default.
- Q59357430 P356 Q59357430-90FB0F11-CC5B-4484-B488-BD0C1EB69A12 @default.
- Q59357430 P407 Q59357430-22E353A1-CB62-499A-8C45-9F8003D7F7FF @default.
- Q59357430 P433 Q59357430-1653E43F-375E-4C1B-93C6-5A6C4BD32494 @default.
- Q59357430 P478 Q59357430-950F6518-ED66-4879-ABE9-CC78B6ED8FCD @default.
- Q59357430 P577 Q59357430-DCDBDA35-C956-4F79-8952-6A6586523BF5 @default.
- Q59357430 P698 Q59357430-04A675CA-0DD2-4A4E-9AC0-8DD35729AAB4 @default.
- Q59357430 P921 Q59357430-9B34E0CF-BEFF-45EB-8832-A08E1368F57A @default.
- Q59357430 P921 Q59357430-B2EDA491-C213-450D-9654-B47DF338C585 @default.
- Q59357430 P921 Q59357430-B9301CDE-EB9C-45E1-8018-C0E84498DB6C @default.
- Q59357430 P921 Q59357430-C5A4E0C2-4CAD-40A9-80E8-DE538E84D3EA @default.
- Q59357430 P356 17425255.2018.1498840 @default.
- Q59357430 P698 29985071 @default.
- Q59357430 P1433 Q5421205 @default.
- Q59357430 P1476 "The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection" @default.
- Q59357430 P2093 "Gueorgui Dubrocq" @default.
- Q59357430 P2093 "Natella Rakhmanina" @default.
- Q59357430 P304 "773-779" @default.
- Q59357430 P31 Q13442814 @default.
- Q59357430 P356 "10.1080/17425255.2018.1498840" @default.
- Q59357430 P407 Q1860 @default.
- Q59357430 P433 "8" @default.
- Q59357430 P478 "14" @default.
- Q59357430 P577 "2018-07-23T00:00:00Z" @default.
- Q59357430 P698 "29985071" @default.
- Q59357430 P921 Q155954 @default.
- Q59357430 P921 Q422631 @default.
- Q59357430 P921 Q422645 @default.
- Q59357430 P921 Q725307 @default.